Authors

• Arangassery Rosemary Bastian
• Nadine C. Salisch (ORCID: https://orcid.org/0000-0002-2951-0800)
• Gunter van Geet
• Benoît Callendret
• Esther Heijnen (ORCID: https://orcid.org/0000-0002-1685-8787)
• Nelson Augusto Rosário Filho (ORCID: https://orcid.org/0000-0002-8550-8051)
• Mika Rämet (ORCID: https://orcid.org/0000-0002-5776-164X)
• Edmund Omoruyi
• Peter Richmond (ORCID: https://orcid.org/0000-0001-7562-7228)
• Terry M. Nolan (ORCID: https://orcid.org/0000-0001-6018-3863)
• Wilbert van Duijnhoven
• Wouter Haazen
• Joanne M. Langley (ORCID: https://orcid.org/0000-0003-3270-7345)
• Kristi L. Williams
• Joanna Williams Durkin
• S Berg

Institutions

• Dalhousie University (CA)
• Janssen (Belgium) (BE)
• The University of Melbourne (AU)
• Tampere University (FI)
• The Kids Research Institute Australia (AU)
• The University of Western Australia (AU)
• Nova Scotia Health Authority (CA)
• Human Vaccines Project Europe (NL)
• Peter Doherty Institute (AU)
• Hospital de Clínicas Universidade Federal do Paraná (BR)
• Murdoch Children's Research Institute (AU)
• Janssen (Netherlands) (NL)

Publication Details

Journal

Open Forum Infectious Diseases

Published

2024-08-08

DOI

https://doi.org/10.1093/ofid/ofae453

Citations

6

Primary Topic

Respiratory viral infections research

Type

article

Field-Weighted Citation Impact

2.32

Funders

• Pfizer
• AstraZeneca
• Sanofi
• Yale University
• Danone
• Regeneron Pharmaceuticals
• Novavax
• Moderna
• Dalhousie University
• Seqirus
• Raymond and Beverly Sackler Institute for Biological, Physical and Engineering Sciences, Yale University